|
0
|
|
NEK2 drives pathogenesis, drug resistance, and LMP1 expression in EBV-positive non-Hodgkin lymphoma.
(pnas.org)
|
White MC
…
Damania B
PNAS
2026-05-19
|
#cancer
#virulence
#amr
#infection
|
|
0
|
|
Systematic evaluation of TCGA tumor microbiota reveals context-dependent reliability.
(journals.asm.org)
|
Ma C
…
Shuai S
mSystems
2026-05-19
|
#microbiome
#cancer
#metagenomics
#benchmarking
#methylation
|
|
0
|
|
NAT10/ac(4)C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling.
(pnas.org)
|
Lu Y
…
Xu J
PNAS
2026-05-19
|
#epigenomics
#transposon
#cancer
#chromatin
#immunity
|
|
0
|
|
ICMT supports BRAF(V600E)-driven tumor growth by membrane targeting of the CAAX protein INPP5E.
(pnas.org)
|
Yang X
…
Bergo MO
PNAS
2026-05-19
|
#amr
#cancer
#melanoma
#signaling
#mutation
|
|
0
|
|
Deep-learning endomicroscope with large field-of-view and depth-of-field for real-time in vivo imaging of epithelial cancer hallmarks.
(pnas.org)
|
Hou H
…
Richards-Kortum RR
PNAS
2026-05-19
|
#imaging
#cancer
#deep learning
#microscopy
#precancer
|
|
0
|
|
Plasma extracellular vesicle proteomics nominates candidate biomarkers of (177)Lu-PSMA-617 outcomes in metastatic prostate cancer patients.
(linkinghub.elsevier.com)
|
Arafa AT
…
Antonarakis ES
Cell Reports Medicine
2026-05-19
|
#proteomics
#biomarker
#cancer
#liquid biopsy
#circulating tumor cell
|
|
0
|
|
A MICA/B GAALIE-mutant antibody elicits potent natural killer cell-driven immunity in solid and hematologic malignancy models.
(linkinghub.elsevier.com)
|
Pimenta R
…
Ferrari de Andrade L
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#antibody
#nk cell
#cancer
#engineering
|
|
0
|
|
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy.
(linkinghub.elsevier.com)
|
Bajgain P
…
St Croix B
Cell Reports Medicine
2026-05-19
|
#car-t
#immunotherapy
#cancer
#phage-display
#humanization
|
|
0
|
|
Overcoming ADC resistance in advanced colorectal cancer by dual targeting of TROP2 and PERK to suppress Wnt/beta-catenin signaling.
(linkinghub.elsevier.com)
|
Liu J
…
Zhang S
Cell Reports Medicine
2026-05-19
|
#cancer
#targeted therapy
#signaling
#combination therapy
#amr
|
|
0
|
|
Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial.
(linkinghub.elsevier.com)
|
Liu Y
…
He LR
Cell Reports Medicine
2026-05-19
|
#radiotherapy
#cancer
#clinical trial
#metastasis
|
|
0
|
|
Antibody-drug conjugates in breast cancer: Progress and future directions.
(linkinghub.elsevier.com)
|
Bili Newman A
…
Meric-Bernstam F
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#cancer
#drug delivery
#biomarker
|
|
0
|
|
Spleen-targeted neoantigen mRNA vaccine induces ISG15(+) CD8(+) T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Lin X
…
Liu X
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#cancer
#neoantigen
#immunity
#vaccination
|
|
0
|
|
Pan-cancer analysis of spatial transcriptomics reveals heterogeneous tumor spatial microenvironment.
(linkinghub.elsevier.com)
|
Li J
…
Li H
Cell Reports Medicine
2026-05-19
|
#transcriptomics
#cancer
#microenvironment
#immunity
|
|
0
|
|
Dual-targeted microspheres reshape the metabolic-immune microenvironment to reverse post-embolization dilemmas in hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Jiang N
…
Cheng L
Cell Reports Medicine
2026-05-19
|
#cancer
#metabolism
#immunity
#immunotherapy
#angiogenesis
|
|
0
|
|
Intracellular sclerostin promotes tumor progression and metastasis as a potential therapeutic target in triple-negative breast cancer.
(linkinghub.elsevier.com)
|
Sun M
…
Zhang G
Cell Reports Medicine
2026-05-19
|
#cancer
#metastasis
#therapeutics
#protein-targeting
|
|
0
|
|
A tumor-intrinsic WNT-inhibitory NOTUM program drives immune resistance in microsatellite stable colorectal cancer.
(linkinghub.elsevier.com)
|
Chua J
…
Ayyaz A
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#cancer
#immune resistance
#colorectal cancer
#tumor microenvironment
|
|
0
|
|
BCAT1-dependent HIF-1alpha stabilization is a targetable metabolic vulnerability in hepatocellular carcinoma.
(linkinghub.elsevier.com)
|
Zhang MS
…
Wong CC
Cell Reports Medicine
2026-05-19
|
#metabolism
#hepatocellular carcinoma
#hypoxia
#cancer
#therapeutics
|
|
0
|
|
Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomes.
(linkinghub.elsevier.com)
|
Shan Y
…
Huang RS
Cell Reports Medicine
2026-05-19
|
#microbiome
#cancer
#immunity
#metagenomics
#transcriptomics
|
|
0
|
|
Reprogramming T cell-myeloid crosstalk overcomes immune resistance in colorectal cancer.
(linkinghub.elsevier.com)
|
Mestrallet G
…
Bhardwaj N
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#cancer
#immunity
#checkpoint
#exhaustion
|
|
0
|
|
An inhalable microbe-oncolytic virus consortium for lung cancer treatment.
(linkinghub.elsevier.com)
|
Ling H
…
Sun M
Cell Reports Medicine
2026-05-19
|
#oncolytic
#immunotherapy
#cancer
#biofilm
#virulence
|
|
0
|
|
MAIT cell enrichment in Lynch syndrome is associated with immune surveillance and colorectal cancer risk.
(gut.bmj.com)
|
Yang H
…
Cadwell K
Gut
2026-05-19
|
#immunity
#cancer
#transcriptomics
#microenvironment
#surveillance
|
|
0
|
|
A ketogenic diet sensitizes pancreatic cancer to glutamine metabolism inhibitors.
(linkinghub.elsevier.com)
|
Hajihassani O
…
Winter JM
Cell Reports Medicine
2026-05-19
|
#metabolism
#cancer
#glutamine
#pancreatic
#therapeutics
|
|
0
|
|
HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results.
(linkinghub.elsevier.com)
|
Braun DA
…
Sommerhalder D
Cell Reports Medicine
2026-05-19
|
#immunotherapy
#cancer
#immunity
#clinical trial
#biomarker
|
|
0
|
|
Targeting RNase H2: A dual-mechanism strategy to elevate replication stress, DNA damage, and antitumor immunity in TNBC.
(linkinghub.elsevier.com)
|
Nguyen TQA
…
Lin SY
Cell Reports Medicine
2026-05-19
|
#cancer
#immunity
#dna damage
#immunotherapy
#virulence
|
|
0
|
|
An autochthonous CRISPR activation screening platform for characterizing tissue-specific oncogene selection.
(linkinghub.elsevier.com)
|
Thege FI
…
Wormann SM
Cell Reports Medicine
2026-05-19
|
#crispr
#cancer
#screening
#oncogene
#tumorigenesis
|
|
0
|
|
Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer.
(linkinghub.elsevier.com)
|
Ho YH
…
Li L
Cell
2026-05-19
|
#immunity
#cancer
#inflammation
#immunotherapy
#neuroimmunology
|
|
0
|
|
A 15-layer multi-omics analysis of gastric cancer ecotypes provides therapeutic insights.
(linkinghub.elsevier.com)
|
Wang Y
…
Zhang B
Cell Reports Medicine
2026-05-19
|
#cancer
#proteomics
#transcriptomics
#microbiome
#metabolism
|
|
0
|
|
Distinct signatures in the human gut and oral microbiomes of gastric cancer.
(linkinghub.elsevier.com)
|
Qin Y
…
Zhou CB
Cell Reports Medicine
2026-05-19
|
#metagenomics
#dysbiosis
#cancer
#microbiome
#metabolism
|
|
0
|
|
Gut microbiome signatures in colorectal neoplasia: a cross-sectional study across neoplasia stages and subtypes.
(gut.bmj.com)
|
Louca P
…
Rees CJ
Gut
2026-05-19
|
#metagenomics
#microbiome
#cancer
#dysbiosis
|
|
0
|
|
DNA methylation biomarkers-based pan-cancer classifier: predictive modeling for cancer classification.
(link.springer.com)
|
Binkowski J
…
Wojdacz TK
Genome Medicine
2026-05-19
|
#methylation
#cancer
#modeling
#biomarker
#classification
|
|
0
|
|
A longitudinal single-cell and spatial multiomic atlas of pediatric high-grade glioma.
(linkinghub.elsevier.com)
|
Sussman JH
…
Tan K
Cell Reports Medicine
2026-05-19
|
#transcriptomics
#proteomics
#cancer
#glioma
#microenvironment
|